Pfizer To Acquire Trillium Therapeutics Inc.

T-Reuters2021-08-23

Trillium Therapeutics Inc :Pfizer To Acquire Trillium Therapeutics Inc..Trillium Therapeutics Inc - Deal For Implied Equity Value Of $2.26 Billion.Trillium Therapeutics Inc - Deal For $18.50 Per Share, In Cash.Trillium Therapeutics Inc - Proposed Deal Of Trillium Is To Be Completed By Way Of A Statutory Plan Of Arrangement Under Business Corporations Act.Trillium Therapeutics Inc - Completion Of Acquisition Is Also Subject To Court And Regulatory Approval, Certain Other Conditions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
2